Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Income ETFs

BIOY vs EIPI: Dividend Yield & Total Return

Share
Share on XDownload as PDF

BIOY and EIPI both write options for income.

askIQ about this page

askIQ about BIOY and EIPI

Net assets on Nov 3, 2026: $1.5m for GraniteShares YieldBOOST Biotech ETF and $1.1bn for FT Energy Income Partners Enhanced Income ETF.

At a glance
26.1%
BIOY cash paid, since launch, May 5, 2026
7.7%
EIPI cash paid, 1 year
+5.4%
BIOY total return, since launch, May 5, 2026
+21.8%
EIPI total return, 1 year
BIOY · since launch to Nov 4, 2026 13.6 pts behind XBI
BIOY
+5.4%
XBI
+19.0%

13.6 pts behind XBI

BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

XBI

+19.0%

BIOY

+5.4%

26.1% as cash

13.6 pts behind XBI

Total return, distributions reinvested

13.6 pts behind XBI

BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

XBI

+19.0%

BIOY

+5.4%

13.6 pts behind XBI

26.1% of it arrived as cash. Total return, distributions reinvested. BIOY since launch: paid 26.1%, price −21.9%, total +5.4%, XBI +19.0%, −13.6 pts. Data to Nov 4, 2026.

Data to Nov 4, 2026.
EIPI · 1 year to Nov 4, 2026 3.8 pts behind its own holdings
EIPI
+21.8%
Own
+25.6%

3.8 pts behind its own holdings

EIPI over 1 year: paid 7.7%, price +13.7%, total +21.8%, its own holdings +25.6%, −3.8 pts. Data to Nov 4, 2026.

its own holdings

+25.6%

EIPI

+21.8%

7.7% of it arrived as cash

3.8 pts behind its own holdings

Total return, distributions reinvested

3.8 pts behind its own holdings

EIPI over 1 year: paid 7.7%, price +13.7%, total +21.8%, its own holdings +25.6%, −3.8 pts. Data to Nov 4, 2026.

its own holdings

+25.6%

EIPI

+21.8%

7.7% of it arrived as cash. Both charts share one scale, with zero at the line. EIPI over 1 year: paid 7.7%, price +13.7%, total +21.8%, its own holdings +25.6%, −3.8 pts. Data to Nov 4, 2026.

Data to Nov 4, 2026.

Pair scorecard

EIPI costs 0.07 points a year less; EIPI is far larger, $1.1bn against $1.5m.

Points (pts) are percentage points.

BIOY vs EIPI: Dividend Yield & Total Return
MeasureBIOYEIPI
Paid and earned
Total return, 1 yearnot published+21.8%
Price changefell 21.9% (since May 5, 2026)rose 13.7% (1 year)
Return of capital, issuer estimate96% of the Sep 22, 2026 payment0% of the Oct 30, 2026 payment
Against its benchmark
BenchmarkBiotech, measured through XBIits own holdings
Cost and size
Expense ratio1.18%1.11%
Net assets, as of Nov 3, 2026$1.5m$1.1bn
Holdings
Holdings in common0%

Method

What they share

0%

By the books each fund has filed, BIOY and EIPI hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 3, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first BIOY EIPI
Only in one fund ↓
Only in BIOY
Only in EIPI
Enterprise Products Partners L.P. 8.56%
Energy Transfer LP 6.48%
MPLX LP 4.47%
Kinder Morgan, Inc. 3.97%
ExxonMobil Holdings Corp. 3.53%
ONEOK, Inc. 3.03%
Shell plc (ADR) 2.79%
Duke Energy Corporation 2.58%
Check overlap with more funds →

Side by side

BIOY GraniteShares YieldBOOST Biotech ETF · Synthetic covered call on XBI, paying weekly EIPI FT Energy Income Partners Enhanced Income ETF · Covered call on its own holdings, paying monthly
Strategy synthetic covered call covered call
Benchmark Biotech (XBI) EIPI's own holdings, without the options (from its filed holdings, rebalanced at each filing; latest Nov 2, 2026)
Pays weekly monthly
Payout rate, annualized 60.7% 6.8%
Expense ratio 1.18% 1.11%
Cash paid, 1 year 26.1% (since launch, May 5, 2026) 7.7%
Price change, 1 year −21.9% (since launch, May 5, 2026) +13.7%
Total return, 1 year +5.4% (since launch, May 5, 2026) +21.8%
Benchmark return, 1 year +19.0% (since launch, May 5, 2026) +25.6%
Ahead or behind −13.6 pts (since launch, May 5, 2026) −3.8 pts
Return of capital, latest estimate 96% 0%
Age 183 days 2.5 years
Net assets, as of Nov 3, 2026 $1.5m $1.1bn

As of Nov 4, 2026. Source: ETFIQ. Cash paid: distributions over the window, as a share of the starting price. Payout rate: the latest payment, annualized, over today’s price.

Window by window

Window by window: BIOY vs EIPI: Dividend Yield & Total Return
Total returnCash paidAgainst the benchmark
WindowBIOYEIPIBIOYEIPIBIOYEIPI
3 months+6.9%+2.2%14.5%1.7%+2.9 pts+0.3 pts
6 months+4.4%+2.5%25.9%3.4%−11.3 pts+1.1 pts
1 year–+21.8%–7.7%–−3.7 pts
Since launchNot the same days: BIOY May 2026 · EIPI May 2024+5.4%+49.6%26.1%24.0%−13.7 ptsnot measured

– means no data for this window. Open this comparison in the app →

Alert

EIPI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BIOY

Over the period from its first trade on May 5, 2026 to Nov 4, 2026, BIOY paid 26.1% of its starting value in cash distributions while its price fell 21.9%. With every distribution reinvested, the fund returned +5.4%. Biotech (XBI) returned +19.0% over the same days, so a holder was behind by 13.6 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 60.7%, paid weekly. GraniteShares estimates that 96% of the distribution paid Sep 22, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.

EIPI

Over the year to Nov 4, 2026, EIPI paid 7.7% of its starting value in cash distributions while its price rose 13.7%. With every distribution reinvested, the fund returned +21.8%. EIPI's own holdings, without the options (from its filed holdings, rebalanced at each filing; latest Nov 2, 2026) returned +25.6% over the same days, so a holder was behind by 3.8 pts. At its price on Nov 4, 2026 the latest distribution annualizes to 6.8%, paid monthly. First Trust estimates that 0% of the distribution paid Oct 30, 2026 was a return of capital (its 19a-1 notice).

Questions people ask

Which is cheaper, BIOY or EIPI?
BIOY charges 1.18% a year and EIPI charges 1.11%, so EIPI is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BIOY against EIPI, data as of Nov 4, 2026. https://etfiq.com/compare/income/bioy-vs-eipi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.